Life Sciences Research Partners VZW;Katholieke Universiteit Leuven
发明人:
申请号：
EP13151001.8
公开号：
EP2623115A1
申请日:
2009.02.16
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a tumour-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the treatment of a tumour or in the treatment or prevention of a tumour relapse, and in the manufacture of medicaments therefore.
